bioRxiv Science⌕ Search

Biology subjects

Mohamad, H.

Publications and source records attributed to Mohamad, H..

2 recordsLinked to original sources

Rapid Progesterone signaling induces meiosis through a dual coreceptor trafficking trap

Agonist-dependent signaling through plasma membrane (PM) receptors takes place through diverse modes, including post-translational modifications, second messengers, formation of signaling complexes, or ionic fluxes among others. Classical signaling downstream of steroid hormones engages nuclear/cytoplasmic receptors to induce transcription. Steroids further signal through a rapid mode within seconds to minutes independently of transcription. Despite the now well-recognized physiological roles of rapid progesterone (P4) signaling, the mechanistic steps remain poorly defined. Here we elucidate the early P4 rapid signaling steps that mediate the release of the oocyte meiotic arrest in the frog. P4 signals through two coreceptors mPR{beta}, which localizes at the PM; and ABHD2, which localizes intracellularly. Binding of P4 increases the interaction affinity between the two coreceptors leading to trapping of ABHD2 at the PM and activating signaling. Although P4 is not required for mPR{beta}-ABHD2 interaction at artificially high receptor concentration, it is essential under physiological conditions. We further show that ABHD2 is a dual pass transmembrane protein that binds P4 leading to intracellular PLA2 activity. Signaling through several receptor classes involves endocytosis, but the mPR{beta}-ABHD2 signaling modality is novel as it employs a PM trafficking trap to form the coreceptor complex and induce meiosis. Hence, our findings define a novel signaling modality for rapid steroid signaling.

cell biology↗

Genetic, clinical underpinnings of subtle early brain change along Alzheimer's dimensions

Alzheimers disease (AD) is associated with heterogeneous atrophy patterns. We employed a semi-supervised clustering technique known as Surreal-GAN, through which we identified two dominant dimensions of brain atrophy in symptomatic mild cognitive impairment (MCI) and AD patients: the "diffuse-AD" (R1) dimension shows widespread brain atrophy, and the "MTL-AD" (R2) dimension displays focal medial temporal lobe (MTL) atrophy. Critically, only R2 was associated with widely known sporadic AD genetic risk factors (e.g., APOE {varepsilon}4) in MCI and AD patients at baseline. We then independently detected the presence of the two dimensions in the early stages by deploying the trained model in the general population and two cognitively unimpaired cohorts of asymptomatic participants. In the general population, genome-wide association studies found 77 genes unrelated to APOE differentially associated with R1 and R2. Functional analyses revealed that these genes were overrepresented in differentially expressed gene sets in organs beyond the brain (R1 and R2), including the heart (R1) and the pituitary gland, muscle, and kidney (R2). These genes were enriched in biological pathways implicated in dendritic cells (R2), macrophage functions (R1), and cancer (R1 and R2). Several of them were "druggable genes" for cancer (R1), inflammation (R1), cardiovascular diseases (R1), and diseases of the nervous system (R2). The longitudinal progression showed that APOE {varepsilon}4, amyloid, and tau were associated with R2 at early asymptomatic stages, but this longitudinal association occurs only at late symptomatic stages in R1. Our findings deepen our understanding of the multifaceted pathogenesis of AD beyond the brain. In early asymptomatic stages, the two dimensions are associated with diverse pathological mechanisms, including cardiovascular diseases, inflammation, and hormonal dysfunction - driven by genes different from APOE - which may collectively contribute to the early pathogenesis of AD.

bioengineering↗